Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.365 AUD | -7.59% | -18.89% | -59.44% |
05-23 | Zelira Therapeutics Receives Third-Tranche of Funding for HOPE Clinical Trials | MT |
04-15 | Zelira Therapeutics Receives AU$919,000 Funding Under Australian Government’s R&D Tax Incentive Scheme | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-59.44% | 2.98M | |
+14.84% | 121B | |
+18.31% | 112B | |
+2.94% | 22.72B | |
-18.26% | 20.82B | |
-18.47% | 16.66B | |
-42.36% | 16.36B | |
-14.23% | 16.19B | |
-0.68% | 13.17B | |
+21.87% | 11.11B |
- Stock Market
- Equities
- ZLD Stock
- News Zelira Therapeutics Limited
- Zelira Therapeutics Receives Third-Tranche of Funding for HOPE Clinical Trials